Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Microbot Medical Inc. (MBOT)

4.25   -0.24 (-5.35%) 12-07 16:00
Open: 4.34 Pre. Close: 4.49
High: 4.4422 Low: 4.22
Volume: 10,413 Market Cap: 34(M)

Technical analysis

as of: 2022-12-07 4:23:54 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 5.43     One year: 6.34
Support: Support1: 3.85    Support2: 3.35
Resistance: Resistance1: 4.65    Resistance2: 5.43
Pivot: 4.29
Moving Average: MA(5): 4.46     MA(20): 4.13
MA(100): 4.77     MA(250): 5.32
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 76.1     %D(3): 86.1
RSI: RSI(14): 49.7
52-week: High: 9.6  Low: 3.35
Average Vol(K): 3-Month: 12 (K)  10-Days: 7 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ MBOT ] has closed above bottom band by 45.3%. Bollinger Bands are 10.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.45 - 4.47 4.47 - 4.49
Low: 4.16 - 4.18 4.18 - 4.21
Close: 4.2 - 4.24 4.24 - 4.28

Company Description

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Headline News

Tue, 06 Dec 2022
Make the Season Merry for Kids With These High-Tech and STEM Toys - Review Geek

Wed, 30 Nov 2022
Whitefish Library Program: Student Landon Jennings reviews 'Skyward' - whitefishpilot.com

Mon, 21 Nov 2022
10 Best Robotic Stocks Under $10 - Yahoo Finance

Fri, 18 Nov 2022
Microbot Medical’s Novel LIBERTY® Robotic System Continues to be Validated with Latest U.S. Design Patent Allowance - Yahoo Finance

Wed, 16 Nov 2022
Telefonica opens Colombian robotics school - Telecompaper EN

Tue, 08 Nov 2022
6 reasons why Downtown Mississauga is the future of urban living | insauga - insauga.com

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. 8 (M)
Shares Float 7 (M)
% Held by Insiders 3 (%)
% Held by Institutions 20.9 (%)
Shares Short 96 (K)
Shares Short P.Month 97 (K)

Stock Financials

EPS -1.71
EPS Est Next Qtl 0
EPS Est This Year -25.03
EPS Est Next Year -15.12
Book Value (p.s.) 0.77
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -65.3
Return on Equity (ttm) -119.9
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -1.79
Qtrly Earnings Growth 0
Operating Cash Flow -12 (M)
Levered Free Cash Flow -7 (M)

Stock Valuations

PE Ratio -2.5
PEG Ratio 0
Price to Book value 5.44
Price to Sales 0
Price to Cash Flow -2.81

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2018-09-04
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.